Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
lung | Lung Cancer

NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer

Posted on January 17, 2022
Post Views: 271

lung | Lung CancerThere are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how the cancer forms including squamous non small cell lung cancer and non squamous non small cell lung cancer. Squamous non small cell lung cancer develops from the flat cells that cover the surface

The UK National Institute for Health and Care Excellence (NICE) approves a combination of pembrolizumab (Keytruda) with chemotherapy drugs to treat a type of NSCLC (non-small cell lung cancer). This new therapy combination will be offered on NHS (National Health Service) in England. These chemotherapy drugs include carboplatin and paclitaxel for treatment of squamous non-small cell lung cancer that has spread to other parts of the body.

Pembrolizumab is an immunotherapy that works by blocking a molecule found on immune cells called PD-1. It helps in killing cancer cells. The drug was approved to treat non small cell lung cancer in combination with chemotherapy drugs, irrespective of whether the tumor tested positive for PD-L1 or not.

This new therapy combination was earlier available in England through the Cancer Drugs Fund and this latest decision comes after pembrolizumab with chemotherapy drugs got approval for NSCLC last year. With this new drug getting approved in combination with carboplatin and paclitaxel, more people can benefit from it. In this therapy, individuals treated with pembrolizumab lived for 17.1 months on an average as compared to 11.6 months for those individuals who were treated with chemotherapy.

The information shared in this blog is for educational purposes only. You should always consult your healthcare professional for any medical need.

Subscribe to our newsletter or follow us on Twitter or Facebook today and never miss an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d